Comparison
BPC-157 vs L-Theanine
Side-by-side of BPC-157 and L-Theanine. Every row below is pulled from the compound schema and will update as our data grows. For deeper reads, follow through to each compound page.
BPC-157
BPC-157 peptide profile: pentadecapeptide body protection compound 157. Preclinical data on tendon, gut healing, recovery. No human RCTs as of 2026.
L-Theanine
L-theanine is a non-protein amino acid found in tea leaves. The most-replicated nootropic; pairs with caffeine at 1:1 (100-200 mg each) for acute focus.
Effects at a glance
BPC-157
- •Preclinical models show accelerated tendon-to-bone and ligament healing after surgical or chemical injury
- •Rodent studies report mucosal protection and faster recovery from NSAID-induced and colitis-induced gut damage
- •Anecdotal human protocols use 250 to 500 mcg twice daily subcutaneously near the injury site
- •No completed phase II or III human RCTs as of 2026, so efficacy and long-term safety remain unestablished
- •Banned by WADA since 2022 under the S0 non-approved substances category for competitive athletes
- •Theoretical angiogenic concern means avoidance is prudent in active malignancy until human data exists
L-Theanine
- •Non-protein amino acid in tea; the most-replicated nootropic in the human RCT literature
- •Caffeine + theanine at 1:1 (100-200 mg each) is the gold-standard acute focus stack
- •Solo doses of 200-400 mg reduce subjective stress and improve sleep quality
- •Increases alpha-wave EEG activity within 30-45 minutes of 200 mg oral dose
- •Crosses blood-brain barrier; bioavailability high, half-life 60-90 minutes
- •Clean safety record; minimal interactions at supplement doses
Side-by-side
| Attribute | BPC-157 | L-Theanine |
|---|---|---|
| Category | peptide | supplement |
| Also known as | Body Protection Compound-157, Pentadecapeptide BPC-157 | theanine, gamma-glutamylethylamide |
| Half-life (hr) ↗ | 4 | 1.5 |
| Typical dose (mg) ↗ | 0.25 | 200 |
| Dosing frequency | daily (anecdotal protocols) | as needed (with caffeine) or daily |
| Routes | subcutaneous, intramuscular, oral | oral |
| Onset (hr) | - | 0.5 |
| Peak (hr) | - | 1 |
| Molecular weight | - | 174.2 |
| Molecular formula | C62H98N16O22 | C7H14N2O3 |
| Mechanism | Proposed upregulation of VEGFR2 and nitric oxide pathways, modulation of growth-hormone receptor expression, and stabilization of gut-brain axis signaling. Mechanism remains largely preclinical. | Crosses BBB; modulates GABA/dopamine/serotonin (modest); increases alpha-wave EEG activity; dampens stress-induced sympathetic response without sedation. |
| Legal status | Not FDA approved; research-use-only grey market; banned by WADA (2022) | OTC dietary supplement |
| WADA status | banned | allowed |
| DEA / Rx | Not FDA approved; not scheduled; research-chemical status | OTC supplement |
| Pregnancy | Insufficient data | Insufficient supplement-dose data; tea-source intake safe |
| CAS | 137525-51-0 | 3081-61-6 |
| PubChem CID | 9941957 | 439378 |
| Wikidata | Q4835418 | Q909931 |
Safety profile
BPC-157
Common side effects
- injection-site irritation
- nausea
- headache (anecdotal)
Contraindications
- pregnancy
- active malignancy (theoretical angiogenic concern)
- no established safety profile in humans
L-Theanine
Common side effects
- mild GI upset (rare)
- headache (rare)
Contraindications
- pregnancy / lactation (insufficient data at supplement doses)
- concurrent strong GABAergics without caution
Interactions
- caffeine: synergistic for acute focus; dampens jitter without blunting alertness(minor)
- benzodiazepines / alcohol: potential additive sedation(minor)
Which Should You Take?
L-Theanine comes out ahead for most readers on the criteria we weight: 3 catalogued goals, OTC dietary supplement, oral dosing, with a Tier-A outcome catalogued. BPC-157 is the right call when one of the conditionals below applies.
- → If your priority is post-training recovery, pick BPC-157.
- → If your priority is gut barrier and microbiome health, pick BPC-157.
- → If your priority is focus or working memory, pick L-Theanine.
- → If your priority is stress and HPA-axis regulation, pick L-Theanine.
Edge case: If you want to avoid research-only / gray-market sourcing, L-Theanine is the more accessible choice.
Default choice: L-Theanine. Lower friction to source, a Tier-A evidence outcome catalogued, and broader goal coverage. Reach for BPC-157 only if your priority sits squarely in the goals it owns above.
This verdict is generated from each compound's schema (goals, legal status, evidence outcomes, dosing route). It updates automatically as our compound data evolves; the deeper read sits on each individual compound page.
Common questions
What is the difference between BPC-157 and L-Theanine?
BPC-157 and L-Theanine differ in category (peptide vs supplement), mechanism, and typical dosing. See the side-by-side table for full details.
Which has a longer half-life, BPC-157 or L-Theanine?
BPC-157 half-life is 4 hours; L-Theanine half-life is 1.5 hours.
Can you stack BPC-157 with L-Theanine?
Stack compatibility depends on mechanism overlap, legal status, and individual response. Check each compound page for specific interactions and contraindications before combining.
Go deeper